Can a single inflammatory marker adequately predict resistance to erythropoiesis-stimulating agents in hemodialysis patients?
dc.creator | Eleftheriadis, T. | en |
dc.creator | Antoniadi, G. | en |
dc.creator | Liakopoulos, V. | en |
dc.creator | Stefanidis, I. | en |
dc.date.accessioned | 2015-11-23T10:26:07Z | |
dc.date.available | 2015-11-23T10:26:07Z | |
dc.date.issued | 2013 | |
dc.identifier | 10.1111/j.1542-4758.2012.00690.x | |
dc.identifier.issn | 1492-7535 | |
dc.identifier.uri | http://hdl.handle.net/11615/27309 | |
dc.source.uri | <Go to ISI>://WOS:000313751100019 | |
dc.subject | DIALYSIS PATIENTS | en |
dc.subject | ANEMIA | en |
dc.subject | Urology & Nephrology | en |
dc.title | Can a single inflammatory marker adequately predict resistance to erythropoiesis-stimulating agents in hemodialysis patients? | en |
dc.type | journalArticle | en |
Files in this item
Files | Size | Format | View |
---|---|---|---|
There are no files associated with this item. |